CIK 0001439725 · Non-accelerated filer<br>Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203986492
- Phone
- 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- 4 Open-market sale CFO, Sec'y & Treasurer sold 988 shares at $0.42 ($411)
- 4 Open-market sale President & CEO sold 3,772 shares at $0.42 ($1,570)
- 4 Open-market sale Chief Commercial Officer sold 476 shares at $0.42 ($198)
- 4 Open-market sale Chief Development Officer sold 442 shares at $0.42 ($184)
- 4 Open-market sale Chief Accounting Officer sold 228 shares at $0.42 ($95)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Option exercise Director acquired 22,874 shares (option exercise)
- 4 Option exercise Director acquired 26,368 shares (option exercise)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 4,723,239 shares at an average $0.28 ($1,316,624)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 5 of 31 · 602 filings